Drik team has rich experience in serving the different industry needs. We help you in focusing on your goals while working together with you on the safety studies required as part of your development activity. Our aim is to provide customized cost-effective studies which provide high quality results within a short time span. Quality in the data generated in the non-GLP programs drive the subsequent GLP studies. Drik at present offers non-GLP (in house) and GLP testing in rodents, dogs and monkey in collaboration with other CROs within USA and outside the country. Your study needs either in terms of cost or quality will be addressed either by us or with our partners.

• Preclinical drug development
• PK/PD study in rodents and dogs
• Short term and long term toxicity studies
• Pharmacology and Toxicology
• Drug induced Liver, Kidney and cardiac toxicity
• Cardiotoxicity hERG Screening in Guinea Pigs

• 3D Slice culture (also known as organ culture) model
• Drug-Drug interactions (P450 inhibition, CYP inhibition)
• ADME

• Orthotopic and Xenograft

• Blood Chemistry, Clinical Pathology
• Histopathology
• Bioanalytical